BiBBInstruments' cancer biopsy device, EndoDrill, has earned high praise from physicians who conducted the first clinical cases at Karolinska University Hospital in Stockholm, Sweden. This positive feedback follows the endorsement of EndoDrill as a "game-changer" in endoscopic ultrasound sampling by the Medical Director of Endoscopy at UC Davis in the US. BioStock spoke with BiBB's CEO Fredrik Lindblad to learn more.

Read the article at biostock.se:

https://www.biostock.se/en/2024/04/bibbs-ceo-patient-cases-fortify-our-confidence-in-endodrill/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

https://news.cision.com/bibbinstruments-ab/r/biostock--bibb-s-ceo----patient-cases-fortify-our-confidence-in-endodrill-,c3959643

(c) 2024 Cision. All rights reserved., source Press Releases - English